BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VEVENT CLASS:PUBLIC CREATED:20180322T134133Z DESCRIPTION:World Preclinical Congress Europe\nWhere Preclinical Minds Meet Discovery Technologies\n\nLocation: Sheraton Lisboa Resort & Spa\nDates: 27-30 November 2018\n\n\nFor 17 years the World Preclinical Congress has b uilt its niche and expertise around bringing together scientists from acad emia and pharma/biotech companies involved in drug discovery. In recent ye ars it has focused predominantly on preclinical research\, highlighting th e various challenges and opportunities that exist in early drug discovery and development. World Preclinical Congress Europe will continue to build on this mission by providing a unique opportunity for scientists and techn ology providers to share ideas and collaborate to accelerate preclinical w ork. The venue in Lisbon\, Portugal provides an ideal\, informal setting f or experts based in the European Union to network with their global counte rparts to build a strong and diverse community to transform preclinical dr ug discovery\n DTEND;VALUE=DATE:20181201 DTSTAMP:20160303T141200Z DTSTART;VALUE=DATE:20181127 LAST-MODIFIED:20180322T134133Z LOCATION:Sheraton Lisboa Resort & Spa\, Lisbon\, Portugal PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:3rd Annual World Preclinical Congress Europe TRANSP:TRANSPARENT UID:040000008200E00074C5B7101A82E00800000000108FB4BE2C75D101000000000000000 010000000C45B2B25609CDB46BA8939F747F5C1B0 X-ALT-DESC;FMTTYPE=text/html:\n\n
\n\n
2nd Annual World Preclinical Congress<
SPAN LANG="en-us">
\n\n
Where Preclinical Minds Meet Discovery Tech nologies
\n\n\n\n
Location: Sheraton Lisboa Resort &\; Spa<
/SPAN>
Dates: 15 – 17 November 2017
\n\nFor 15 years the
I>
SPAN>
World Preclin
ical Congress has built its nic
he and expertise around bringing together scientists from academia and pha
rma/biotech companies involved in drug discovery. In recent years it has
FONT> focused pr
edominantly on preclinical research\, highlighting the various challenges
and opportunities that exist in early drug discovery and development.
I> World Precl
inical Congress Europe